secwatch.observer — SEC 8-K summary
======================================

Issuer:     SYNLOGIC, INC. (SYBX)
CIK:        0001527599
Form:       8-K
Filed at:   2022-05-12T23:59:59+00:00
Accession:  0001193125-22-148082
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Synlogic reports Q1 net loss of $15.7M; cash $120.5M supports runway into 2024
------------------------------------------------------------------------------

- Net loss of $15.7M ($0.22/share) vs $15.0M ($0.36/share) in Q1 2021.
- Revenue of $0.2M from Roche collaboration; no revenue in Q1 2021.
- Cash, cash equivalents and short-term investments $120.5M; expected funding into 2024.
- PKU program progressing to Phase 3 readiness; expects Phase 2 data and candidate selection in H2 2022.
- Michael Jensen appointed CFO in March 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527599/000119312522148082/0001193125-22-148082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527599/000119312522148082/d337665d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-148082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer